Skantze K A, Brinckerhoff C E, Collier J P
Cancer Res. 1985 Sep;45(9):4416-21.
Nonneoplastic cell lines are unable to grow in soft agar. However, concomitant treatment of these cells with epidermal growth factor and transforming growth factor beta confers upon them anchorage independence. Since articular chondrocytes are unique as normal diploid cells that do have the capability of growing in soft agar, we tested whether transforming growth factor beta and epidermal growth factor could affect DNA synthesis and matrix production. In the presence of epidermal growth factor (5 ng/ml) concentrations of high-performance liquid chromatography-purified transforming growth factor beta at concentrations of 0.05-15 ng/ml induced a dose-dependent increase in DNA, to nearly double that of control cultures. A half-maximal effect was seen with transforming growth factor beta, 0.1 ng/ml, and epidermal growth factor, 5 ng/ml. Neither compound alone was mitogenic. In contrast, either transforming growth factor beta or epidermal growth factor alone was able to decrease synthesis of glycosaminoglycans and collagen. The data demonstrate that transforming growth factors can affect the behavior of nonneoplastic cells by modulating cell replication and the biosynthesis of two principal matrix components. In addition they support the hypothesis that these growth factors may play a role in the physiology of nonmalignant cells.
非肿瘤细胞系无法在软琼脂中生长。然而,用表皮生长因子和转化生长因子β同时处理这些细胞可使其获得锚定非依赖性。由于关节软骨细胞作为正常二倍体细胞具有在软琼脂中生长的能力,我们测试了转化生长因子β和表皮生长因子是否会影响DNA合成和基质产生。在存在表皮生长因子(5 ng/ml)的情况下,高效液相色谱纯化的转化生长因子β浓度为0.05 - 15 ng/ml时可诱导DNA呈剂量依赖性增加,接近对照培养物的两倍。转化生长因子β 0.1 ng/ml和表皮生长因子5 ng/ml时可观察到半数最大效应。单独使用这两种化合物均无促有丝分裂作用。相反,单独的转化生长因子β或表皮生长因子均能够减少糖胺聚糖和胶原蛋白的合成。数据表明,转化生长因子可通过调节细胞复制和两种主要基质成分的生物合成来影响非肿瘤细胞的行为。此外,它们支持这些生长因子可能在非恶性细胞生理学中发挥作用这一假说。